Skip to main content
. 2012 Dec 29;30(2):239–245. doi: 10.1007/s10815-012-9919-3

Table 2.

Cycle outcomes of patients treated with uhCG or rhCG

Variable Group A uhCG n = 60 Group B rhCG 250 μg n = 60 Group C rhCG 500 μg n = 60 p-value
Duration of stimulation (day) 10.13 ± 1.50 10.37 ± 1.54 10.37 ± 1.40 0.60
Total dose of FSH required (IU) 1626 ± 385.77 1647 ± 614.74 1586 ± 321.42 0.75
Endometrial thickness(mm) 9.7 ± 1.38 9.6 ± 1.74 10.01 ± 1.58 0.35
Number of aspirated Follicles 16.27 ± 7.80 17.65 ± 7.73 16.08 ± 6.81 0.45
Number of retrieved oocytes 11.37 ± 5.3 12.40 ± 6.44 12.25 ± 5.30 0.56
Number of retrieved oocytes per aspirated follicles 71.82 ± 15.09 69.84 ± 17.44 77.16 ± 17.61 a 0.04
Number of metaphase II oocytes (MII) 9.62 ± 4.50 10.67 ± 5.88 10.75 ± 5.07 0.41
Number of immature oocytes (MI&GV) 1.41 ± 2.64 1.11 ± 1.53 1.15 ± 1.60 0.66
Fertilization rate 61.2(364/595) 64.1(408/637) 59.8(383/640) 0.28
Number of produced embryos 6.18 ± 3.78 6.98 ± 5.02 6.62 ± 3.67 0.58
Number of excellent quality embryos 1.60 ± 2.14 2.40 ± 3.04 1.85 ± 2.00 0.18
Number of good quality embryos 2.30 ± 1.90 2.20 ± 1.92 2.12 ± 1.60 0.85
Number of transferred embryos 2.07 ± .95 1.72 ± 1.13 2.15 ± .84 0.06
Number of embryos frozen 2.05 ± 2.82 3.12 ± 3.94 2.40 ± 3.02 0.19

Values are expressed as mean ± standard deviation or number (percentage)

aGroup C versus group B (P = .04)